Filing Details
- Accession Number:
- 0001209191-12-034488
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-06-19 14:29:40
- Reporting Period:
- 2012-06-15
- Filing Date:
- 2012-06-19
- Accepted Time:
- 2012-06-19 14:29:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1339455 | Somaxon Pharmaceuticals Inc. | SOMX | Pharmaceutical Preparations (2834) | 200161599 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1173408 | L.p. Iii Bioventures Mpm | C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116 | No | No | Yes | No | |
1173409 | L.p. Iii-Qp Bioventures Mpm | C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116 | No | No | Yes | No | |
1249063 | Mpm Bioventures Iii Parallel Fund, L.p. | C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116 | No | No | Yes | No | |
1249133 | Mpm Bioventures Iii Gmbh & Co. Beteiligungs Kg | C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116 | No | No | Yes | No | |
1249143 | L.p. Gp Iii Bioventures Mpm | C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116 | No | No | Yes | No | |
1249147 | Mpm Bioventures Iii Llc | C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116 | No | No | Yes | No | |
1346986 | Mpm Asset Management Investors 2005 Bviii Llc | C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-06-15 | 1,450 | $0.29 | 3,781,735 | No | 4 | S | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See Footnote |
Footnotes
- The shares were sold as follows: 1,209 by MPM BioVentures III-QP, L.P. ("BV III QP"), 81 by MPM BioVentures III, L.P. ("BV III"), 21 by MPM Asset Management Investors 2005 BVIII LLC ("AM 2005"), 37 by MPM BioVentures III Parallel Fund, L.P. ("BV Parallel") and 102 by MPM BioVentures III GmbH & Co. Beteiligungs KG ("BV KG"). MPM BioVentures III GP, L.P. ("MPM III GP") and MPM BioVentures III LLC ("MPM III LLC") are the direct and indirect general partners of BV III QP, BV III, BV Parallel and BV KG. Luke Evnin, Ansbert Gadicke, Nicholas Galakatos, Dennis Henner, Nicholas Simon III, Michael Steinmetz and Kurt Wheeler are the Series A members of MPM III LLC and the managers of AM 2005.
- The shares are held as follows: 3,152,321 by BV III QP, 211,966 by BV III, 55,842 by AM 2005, 95,222 by BV Parallel and 266,384 by BV KG. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.